Table 7.
Reference | Group | Characteristics | β | Wald | Exp(β) | 95 % CI | p value |
---|---|---|---|---|---|---|---|
Group 1 (n = 561) | Group 2 (n = 137) | TPU/CrU_t | 0.92 | 59.61 | 2.50 | 1.98 to 3.16 | <0.001 |
Hb_t | −0.53 | 34.97 | 0.59 | 0.49 to 0.70 | <0.001 | ||
UA_t | 0.71 | 32.94 | 2.04 | 1.60 to 2.60 | <0.001 | ||
Sex(M) | 1.04 | 10.47 | 2.82 | 1.51 to 5.28 | 0.001 | ||
P_t | 1.03 | 9.60 | 2.79 | 1.46 to 5.35 | 0.002 | ||
CRP_t | 0.74 | 5.51 | 2.09 | 1.13 to 3.85 | 0.019 | ||
Group 3 (n = 72) | TPU/CrU_t | 1.33 | 74.77 | 3.78 | 2.79 to 5.10 | <0.001 | |
Hb_t | −0.93 | 35.05 | 0.40 | 0.29 to 0.54 | <0.001 | ||
P_t | 2.80 | 32.95 | 16.41 | 6.31 to 42.64 | <0.001 | ||
UA_t | 0.86 | 19.45 | 2.36 | 1.61 to 3.45 | <0.001 | ||
Sex(M) | 1.90 | 14.94 | 6.71 | 2.56 to 17.61 | <0.001 | ||
CRP_t | 1.25 | 6.51 | 3.48 | 1.34 to 9.08 | 0.011 | ||
Group 2 | Group 3 | P_t | 1.77 | 19.75 | 5.88 | 2.69 to 12.83 | <0.001 |
TPU/CrU_t | 0.41 | 14.77 | 1.51 | 1.22 to 1.86 | <0.001 | ||
Hb_t | −0.40 | 8.09 | 0.67 | 0.51 to 0.88 | 0.004 | ||
Sex(M) | 0.87 | 4.18 | 2.38 | 1.04 to 5.46 | 0.041 | ||
Group 1 + 2 | Group 3 | TPU/CrU_t | 0.58 | 19.84 | 1.78 | 1.38 to 2.29 | <0.001 |
P_t | 1.87 | 19.47 | 6.49 | 2.83 to 14.89 | <0.001 | ||
eGFR_0 | −0.05 | 7.67 | 0.95 | 0.92 to 0.99 | 0.006 | ||
Sex(M) | 1.15 | 7.56 | 3.17 | 1.39 to 7.21 | 0.006 | ||
Alb_t | −1.33 | 7.02 | 0.26 | 0.10 to 0.71 | 0.008 | ||
Hb_t | −0.38 | 6.36 | 0.68 | 0.51 to 0.92 | 0.012 |
Groups 1, 2, and 3 correspond to % decline of eGFR per year <10 %, 10–25 % and >25 %, respectively
Independent variables included age, sex, eGFR_0, DMN, SBP_t, Hb_t, Alb_t, UA_t, Na_t, K_t, Na-Cl_t, cCa_t, P_t, CRP_t, LDL-C_t, TPU/CrU_t, UB_score_t, RASi_t